CN117658866A - Synthesis method of azido amino acid derivative - Google Patents
Synthesis method of azido amino acid derivative Download PDFInfo
- Publication number
- CN117658866A CN117658866A CN202311670792.9A CN202311670792A CN117658866A CN 117658866 A CN117658866 A CN 117658866A CN 202311670792 A CN202311670792 A CN 202311670792A CN 117658866 A CN117658866 A CN 117658866A
- Authority
- CN
- China
- Prior art keywords
- formula
- amino acid
- iii
- acid derivative
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 azido amino Chemical group 0.000 title claims abstract description 52
- 238000001308 synthesis method Methods 0.000 title claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 29
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 230000005855 radiation Effects 0.000 claims abstract description 24
- 150000001540 azides Chemical class 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- 239000003223 protective agent Substances 0.000 claims abstract description 9
- 125000006239 protecting group Chemical group 0.000 claims abstract description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 23
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical group CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 3
- 229960002317 succinimide Drugs 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 2
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims 9
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 31
- 235000019439 ethyl acetate Nutrition 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- OXNUZCWFCJRJSU-UHFFFAOYSA-N 2-azaniumyl-3-[4-(hydroxymethyl)phenyl]propanoate Chemical compound OC(=O)C(N)CC1=CC=C(CO)C=C1 OXNUZCWFCJRJSU-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- OGLFMTLLZNGZPP-UHFFFAOYSA-N 2-amino-3-[3-(hydroxymethyl)phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(CO)=C1 OGLFMTLLZNGZPP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a synthesis method of an azido amino acid derivative, which comprises the following steps: step S1, reacting a compound represented by the formula (II)Reacting with an amino protecting agent to produce a compound represented by the formula (III)Step S2, the compound shown in the formula (III) and an azide source are reacted in the presence of a catalyst and a solvent to generate the compound shown in the formula (I) under the action of infrared radiationI.e. the azido amino acid derivative; in the formula (I)The R is 1 is-CH 2 ‑N 3 The method comprises the steps of carrying out a first treatment on the surface of the In the formula (I) and the formula (III), R is 2 Is an amino protecting group; in the formula (II) and the formula (III), R is 3 is-CH 2 -OH. The synthesis method of the invention uses the 2-amino-hydroxymethyl-phenyl propionic acid derivative as a starting material, firstly performs amino protection on the derivative, and then converts hydroxyl into azide groups under the actions of infrared radiation and a catalyst, thus having high yield and simple operation. Furthermore, the use of a strong toxic azide source is avoided, the safety is higher, and the method is more suitable for industrial production.
Description
Technical Field
The invention belongs to the technical field of synthesis of organic compounds, and particularly relates to a synthesis method of an azido amino acid derivative.
Background
Unnatural amino acids have found widespread use in the study of proteins, nucleosides, and nucleic acids as part of amino acids: the non-natural amino acid is doped into protein sequence to design new protein, which has important significance in researching the folding and function of natural protein. To date, more than 30 unnatural amino acids have been artificially inserted into the natural proteins synthesized by living organisms. Furthermore, the presence of unnatural amino acids can limit the flexibility of polypeptide conformation, provide deoxyribonucleic acid or ribonucleic acid molecules with stable secondary structures, enhance the stability of polypeptides to enzymes, and enhance pharmacokinetics and biological activity. Therefore, efficient synthesis of unnatural amino acids has become an important topic of research in the chemical and biochemical fields.
Attachment of azide groups to amino acid molecular structures has an important impact on the properties and function of amino acids. First, the presence of azide enables amino acids to form polypeptide chains, which link amino acid molecules together through peptide bonds, thus constituting proteins. Secondly, azide also participates in the regulation of the acid-base and hydrophilic properties of amino acids, affecting the solubility and interaction of amino acids. Whereas the commonly used azide source is NaN 3 However, naN is used 3 As an azide source, the material is easy to explode, and not only is easy to explode due to friction, collision, vibration and the like, but also has strong toxicity and poor safety.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a synthesis method of an azido amino acid derivative with high safety, and the synthesis method is simple to operate, high in yield and suitable for industrial production.
In order to achieve the purpose, the invention adopts the following technical scheme:
a synthesis method of azido amino acid derivatives is provided, wherein the structural formula of the azido amino acid derivatives is shown as formula (I),
the synthesis method comprises the following steps:
step S1, reacting a compound shown in a formula (II) with an amino protective agent to generate a compound shown in a formula (III);
s2, enabling the compound shown in the formula (III) and an azide source to generate the compound shown in the formula (I) under the action of infrared radiation in the presence of a catalyst and a solvent;
the structural formula of the compound shown in the formula (II) is as follows:
the structural formula of the compound shown in the formula (III) is as follows:
in the formula (I), the R 1 is-CH 2 -N 3 The method comprises the steps of carrying out a first treatment on the surface of the In the formula (I) and the formula (III), R is 2 Is an amino protecting group; in the formula (II) and the formula (III), R is 3 is-CH 2 -OH。
In some embodiments, in formula (I), the R 1 Is CH on benzene ring 2 Para, meta or ortho to the group; in the formula (II) and the formula (III), R is 3 Is CH on benzene ring 2 Para, meta or ortho to the group.
In some embodiments, the compound of formula (I) is as follows:
in some embodiments, in step S2, the infrared radiation has a power of 200 to 350W and a radiation temperature of 10 to 40 ℃.
Further, the infrared radiation has a power of 250-300W.
In some embodiments, in step S2, the infrared radiation is for a period of 4 to 8 hours.
In some embodiments, in step S2, the azide source is one or a combination of diphenyl phosphoryl azide (DPPA), azido trimethylsilane. NaN with strong toxicity avoidance 3 The use of the azide source avoids explosion and has higher safety.
In some embodiments, in step S2, the solvent is one or a combination of several of acetone, n-hexane, toluene, dimethyl sulfoxide (DMSO); the catalyst is one or a combination of a plurality of 1, 5-diazabicyclo [4.3.0] -5-nonene (DBN), 1, 8-diazabicyclo [5.4.0] undec-7-ene (DBU) and Tetramethylguanidine (TMG).
Preferably, in step S2, the solvent is a mixture of acetone and n-hexane. Avoiding the use of toxic solvents such as toluene and the like, and being beneficial to improving the yield of the product.
Further, the volume ratio of the acetone to the n-hexane is 1:0.8-1.2.
Advantageously, the azide source adopts diphenyl phosphoryl azide, the solvent adopts a mixture of acetone and n-hexane, and the reaction is carried out under infrared radiation, so that the reaction can be greatly promoted, the reaction time is greatly shortened, the product yield is high, the experimental operation is simple, the post-treatment is simple, other auxiliary solvents are not needed, and the cost is reduced.
In some embodiments, in step S2, the reaction is performed under an inert gas atmosphere. Such as nitrogen.
In some embodiments, the molar ratio of the compound of formula (III) to the azide source is 1:1 to 1.5; the feeding mole ratio of the compound shown in the formula (III) to the catalyst is 1:0.8-1.2.
In some embodiments, the implementation of step S2 is as follows: under the condition of inert gas, the compound shown in the formula (III) is dissolved in a solvent, then an azide source and a catalyst are added into the system under the condition of ice bath, then the reaction is carried out under the condition of infrared radiation at the temperature of 10-40 ℃, and after the reaction is finished, the reaction is quenched.
In some embodiments, the synthesis method further comprises the step of post-treating the reaction solution after the quenching reaction is completed, wherein the post-treatment comprises drying, spin-drying the solvent and purifying by a chromatographic column.
In some embodiments, the R 2 Boc, fmoc; the amino protecting agent is selected from di-tert-butyl dicarbonate and fluorenylmethoxycarbonyl succinimide (Fmoc-OSu).
In some embodiments, in step S1, the reaction is performed in the presence of a solvent, the solvent being a mixture of an organic solvent and water, the organic solvent being one or a combination of several of dioxane, tetrahydrofuran, N-dimethylformamide.
In some embodiments, in step S1, the reaction is performed at 15 to 40 ℃, and the reaction is performed in the presence of a base, where the base is one or a combination of several of sodium carbonate, sodium hydroxide, sodium bicarbonate, potassium carbonate, and potassium tert-butoxide.
In some embodiments, when the amino protecting agent is di-tert-butyl dicarbonate, the implementation of step S1 is: under ice bath condition, adding the compound shown in the formula (II), a solvent and alkali into a reactor, adding an amino protective agent and alkali into the reactor, reacting for 6-10 hours at 15-40 ℃, spin-drying the solvent, diluting with ethyl acetate in ice bath, acidifying to pH of 2-3, extracting, washing with water, combining organic phases, drying and spin-drying to obtain the compound shown in the formula (III).
In some embodiments, when the amino protecting agent is fluorenylmethoxycarbonyl succinimide, the implementation of step S1 is: under ice bath condition, amino protective agent is dissolved in solvent and then added into a reactor filled with compound shown in formula (II), solvent and alkali, and the compound shown in formula (III) is obtained through reaction for 6-10 h at 15-40 ℃, extraction, pH value adjustment to 1-3, extraction, weak acid water washing, drying, concentration and recrystallization.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages:
the synthesis method of the invention uses the 2-amino-hydroxymethyl-phenyl propionic acid derivative as a starting material, firstly performs amino protection on the derivative, and then converts hydroxyl into azide groups under the actions of infrared radiation and a catalyst, thus having high yield and simple operation. Furthermore, the use of a strong toxic azide source is avoided, the safety is higher, and the method is more suitable for industrial production.
Drawings
FIG. 1 is a nuclear magnetic resonance spectrum of 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid of example 1.
Detailed Description
The following detailed description of the present invention is provided in connection with specific embodiments so that those skilled in the art may better understand and practice the present invention, but is not intended to limit the scope of the present invention.
The starting materials may be obtained commercially, or prepared by methods known in the art, or prepared according to the methods described herein.
The structure of the compound was obtained by nuclear magnetic resonance (1H-NMR). The NMR measurement was performed using an ACF-400BRUKER type nuclear magnetic resonance apparatus, and the solvent was deuterated chloroform (CDCl) 3 ) Or deuterated dimethyl sulfoxide (DMSO-D) 6 ) Or heavy water (D) 2 O), TMS is an internal standard. Column chromatography adopts 200-300 mesh silica gel (produced by Qingdao ocean chemical plant).
Example 1
This example provides the synthesis of 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid
The synthesis method comprises the following steps:
step S1, 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid (1.95 g,10 mmol), dioxane/H under ice bath conditions 2 O (v/v=2:1, 30 mL), naOH (1M, 10 mmol) was added to a 150mL round bottom flask. Will (Boc) 2 O (Boc anhydride) (3.27 g,15 mmol) and NaHCO 3 (10 mmol) was added to the reaction mixture and reacted at room temperature overnight for 8h. The solvent was dried by spinning, the residue diluted with ethyl acetate (40 mL) in an ice bath and acidified with 1.0M HCl to ph=2-3. The aqueous phase was extracted with EtOAc (2X 20 mL), and the organic phases were combined after multiple water washes, anhydrous Na 2 SO 4 Dried and spun-dried to give 2- ((tert-butoxycarbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (2.9 g, 98.1%).
Step S2, at N 2 2- ((tert-Butoxycarbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (2.95 g,10 mmol) was dissolved in a mixed solution of acetone and n-hexane (1:1) (10 mL) under the conditions. Diphenylphosphorylazide (3.0 g,11 mmol) and DBN (1.3 g,10.5 mmol) were then added rapidly to the mixture under ice-bath conditions followed by stirring at room temperature for 6h with infrared radiation from an infrared radiation meter (220 v 275 w). After the reaction was completed, the reaction was quenched with water (10 mL) and 5% aqueous HCl (10 mL) in this order. The reaction mixture was extracted with EtOAc (2X 10 mL). With anhydrous MgSO 4 The solvent was dried and spun dry. Purification by column chromatography followed by elution with hexane/EtOAc (V/v=20/1) afforded 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid (3.17 g, 99.1%).
Nuclear magnetic results:
1 H NMR(400MHz,CDCl 3 )δ8.03(s,1H),7.30(dt,2H),6.96(dt,2H),6.67(d,1H),4.24(m,3H),3.05(m,2H),1.41(s,9H)。
example 2
This example provides the synthesis of 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (4- (azidomethyl) phenyl) propanoic acid
The synthesis method comprises the following steps:
step S1 Fmoc-OSu (1.35 g,4 mmol) was dissolved in tetrahydrofuran (10 mL) at 0deg.C and added to 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid (0.78 g,4 mmol) in 12mL10% Na 2 CO 3 In solution, the mixture was stirred at room temperature overnight for 7h. After the reaction, the mixture was extracted with PE, followed by adjusting pH to 2, extraction with ethyl acetate (20 ml. Times.3), washing with acetic acid, drying, concentration, and recrystallization gave 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (1.6 g, 96.5%).
Step S2, at N 2 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (4.17 g,10 mmol) was dissolved in a mixed solution of acetone and n-hexane (1:1) (10 mL) under the conditions. Diphenylphosphorylazide (3.0 g,11 mmol) and DBN (1.3 g,10.5 mmol) were then added rapidly to the mixture under ice-bath conditions followed by stirring at room temperature for 7h with infrared radiation from an infrared radiation meter (220 v 275 w). After the reaction was completed, the reaction was quenched with water (10 mL) and 5% aqueous HCl (10 mL) in this order. The reaction mixture was extracted with EtOAc (2X 10 mL). With anhydrous MgSO 4 The solvent was dried and spun dry. Purification by column chromatography followed by elution with hexane/EtOAc (V/v=20/1) afforded 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (4- (azidomethyl) phenyl) propanoic acid (4.39 g, 99.3%).
Nuclear magnetic results:
1 H NMR(400MHz,DMSO)δ10.11(s,1H),7.65(m,8H),7.30(dt,2H),6.91(dt,2H),6.18(d,1H),5.60(m,1H),4.36(d,2H),4.25(m,3H),3.06(dq,2H)。
example 3
This example provides the synthesis of 3- (3- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid
This example uses 10mmol of 2-amino-3- (3- (hydroxymethyl) phenyl) propionic acid instead of 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid, and the total yield of final 3- (3- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid was 97.1%.
1 H NMR(400MHz,CDCl 3 )δ8.24(s,1H),7.33(dp,1H),7.23(t,1H),7.13(hept,1H),7.01(dq,1H),6.67(d,1H),4.21(m,3H),3.08(ddt,1H),3.01(ddt,1H),1.41(s,9H)。
Example 4
This example provides the synthesis of 3- (2- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid
This example uses 10mmol of 2-amino-3- (2- (hydroxymethyl) phenyl) propionic acid instead of 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid, and the total yield of final 3- (2- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid was 96.9%.
1 H NMR(400MHz,CDCl 3 )δ8.11(s,1H),7.30(ddt,1H),7.23(td,1H),7.16(td,1H),7.00(dq,1H),6.90(d,1H),4.33(m,2H),4.24(dt,1H),3.09(m,2H),1.45(s,9H)。
Example 5
This example provides the synthesis of 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (3- (azidomethyl) phenyl) propanoic acid
This example uses 10mmol of 2-amino-3- (3- (hydroxymethyl) phenyl) propionic acid instead of 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid, the overall yield of final 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (3- (azidomethyl) phenyl) propionic acid was 97.3%.
1 H NMR(400MHz,DMSO)δ9.93(s,1H),7.81(dd,2H),7.70(m,2H),7.60(td,2H),7.52(td,2H),7.33(m,1H),7.24(t,1H),7.13(hept,1H),6.99(m,1H),6.38(d,1H),5.41(m,1H),4.36(d,2H),4.23(m,1H),4.18(m,2H),3.05(m,2H)。
Example 6
This example provides the synthesis of 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (2- (azidomethyl) phenyl) propanoic acid
This example uses 10mmol of 2-amino-3- (2- (hydroxymethyl) phenyl) propionic acid instead of 2-amino-3- (4- (hydroxymethyl) phenyl) propionic acid, the overall yield of final 2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -3- (2- (azidomethyl) phenyl) propionic acid was 96.6%.
1 H NMR(400MHz,DMSO)δ9.82(s,1H),7.81(dd,2H),7.70(m,2H),7.60(td,2H),7.52(td,2H),7.30(ddt,1H),7.22(dtd,2H),6.95(ddt,1H),6.52(d,1H),5.61(m,1H),4.35(m,4H),4.24(dt,1H),3.07(m,2H)。
Example 7
This example provides the synthesis of 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid, the synthesis method being essentially the same as in example 1, except that: 10mL of toluene was used instead of the acetone and n-hexane mixed solution.
At N 2 2- ((tert-Butoxycarbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (2.95 g,10 mmol) was dissolved in toluene solution (10 mL) under conditions. Diphenylphosphorylazide (3.0 g,11 mmol) and DBN (1.3 g,10.5 mmol) were then added rapidly to the mixture under ice-bath conditions followed by stirring at room temperature for 6h with infrared radiation from an infrared radiation meter (220 v 275 w). After the reaction was completed, the reaction was quenched with water (10 mL) and 5% aqueous HCl (10 mL) in this order. The reaction mixture was extracted with EtOAc (2X 10 mL). With anhydrous MgSO 4 The solvent was dried and spun dry. Purification by column chromatography followed by elution with hexane/EtOAc (V/v=20/1) afforded 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid (2.7 g, 85%).
Example 8
This example provides the synthesis of 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid, the synthesis method being essentially the same as in example 1, except that: DBU is used instead of DBN.
At N 2 2- ((tert-Butoxycarbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (2.95 g,10 mmol) was dissolved in a mixed solution of acetone and n-hexane (1:1) (10 mL) under the conditions. Diphenylphosphorylazide (3.0 g,11 mmol) and DBU (1.6 g,10.5 mmol) were then added rapidly to the mixture under ice-bath conditions followed by stirring at room temperature for 6h with infrared radiation from an infrared radiation meter (220 v 275 w). After the reaction was completed, the reaction was quenched with water (10 mL) and 5% aqueous HCl (10 mL) in this order. The reaction mixture was extracted with EtOAc (2X 10 mL). With anhydrous MgSO 4 The solvent was dried and spun dry. Purification by column chromatography followed by elution with hexane/EtOAc (V/v=20/1) afforded 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid (2.85 g, 89%).
Comparative example 1
This comparative example provides the synthesis of 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propionic acid, the synthesis method being essentially the same as in example 1, except that: in step S2, infrared radiation is performed without using an infrared radiation meter.
At N 2 2- ((tert-Butoxycarbonyl) amino) -3- (4- (hydroxymethyl) phenyl) propanoic acid (2.95 g,10 mmol) was dissolved in a mixed solution of acetone and n-hexane (1:1) (10 mL) under the conditions. Then diphenylphosphorylazide (3.0 g,11 mmol), DBN (1.3 g,10.5 mmol) were added rapidly to the mixture under ice-bath conditions and the reaction stirred at room temperature for 6h. After the reaction was completed, the reaction was quenched with water (10 mL) and 5% aqueous HCl (10 mL) in this order. The reaction mixture was extracted with EtOAc (2X 10 mL). With anhydrous MgSO 4 The solvent was dried and spun dry. Purification by column chromatography followed by elution with hexane/EtOAc (V/v=20/1) afforded 3- (4- (azidomethyl) phenyl) -2- ((tert-butoxycarbonyl) amino) propanoic acid (1.6 g, 50%).
The above embodiments are provided to illustrate the technical concept and features of the present invention and are intended to enable those skilled in the art to understand the content of the present invention and implement the same, and are not intended to limit the scope of the present invention. All equivalent changes or modifications made in accordance with the spirit of the present invention should be construed to be included in the scope of the present invention.
The endpoints and any values of the ranges disclosed herein are not limited to the precise range or value, and are understood to encompass values approaching those ranges or values. For numerical ranges, one or more new numerical ranges may be found between the endpoints of each range, between the endpoint of each range and the individual point value, and between the individual point value, in combination with each other, and are to be considered as specifically disclosed herein.
Claims (10)
1. A synthesis method of azido amino acid derivatives is provided, wherein the structural formula of the azido amino acid derivatives is shown as formula (I),
the synthesis method is characterized by comprising the following steps of:
step S1, reacting a compound shown in a formula (II) with an amino protective agent to generate a compound shown in a formula (III);
s2, enabling the compound shown in the formula (III) and an azide source to generate the compound shown in the formula (I) under the action of infrared radiation in the presence of a catalyst and a solvent;
the structural formula of the compound shown in the formula (II) is as follows:
the structural formula of the compound shown in the formula (III) is as follows:
in the formula (I), the R 1 is-CH 2 -N 3 The method comprises the steps of carrying out a first treatment on the surface of the In the formula (I) and the formula (III), R is 2 Is an amino protecting group; in the formula (II) and the formula (III)The R is 3 is-CH 2 -OH。
2. The method for synthesizing an azido amino acid derivative according to claim 1, characterized in that: in the step S2, the power of the infrared radiation is 200-350W, and the radiation temperature is 10-40 ℃.
3. The method for synthesizing an azido amino acid derivative according to claim 2, characterized in that: in the step S2, the time of the infrared radiation is 4-8 h.
4. The method for synthesizing an azido amino acid derivative according to claim 1, characterized in that: in the step S2, the azide source is one or a combination of more of diphenyl phosphoryl azide and azido trimethylsilane.
5. The method for synthesizing an azido amino acid derivative according to claim 1, characterized in that: in the step S2, the solvent is one or a combination of more of acetone, normal hexane, dimethyl sulfoxide and toluene; and/or the catalyst is one or a combination of a plurality of 1, 5-diazabicyclo [4.3.0] -5-nonene, 1, 8-diazabicyclo [5.4.0] undec-7-ene and tetramethyl guanidine.
6. The method for synthesizing an azido amino acid derivative according to claim 5, characterized in that: in step S2, the solvent is a mixture of acetone and n-hexane.
7. The method for synthesizing an azido amino acid derivative according to claim 1, characterized in that: in step S2, the reaction is performed under an inert gas atmosphere; and/or the feeding mole ratio of the compound shown in the formula (III) to the azide source is 1:1-1.5; and/or the feeding mole ratio of the compound shown in the formula (III) to the catalyst is 1:0.8-1.2.
8. The method for synthesizing an azido amino acid derivative according to any of claims 1-7, characterized in that: the implementation of the step S2 is as follows: under the condition of inert gas, the compound shown in the formula (III) is dissolved in a solvent, then an azide source and a catalyst are added into the system under the condition of ice bath, then the reaction is carried out under the condition of infrared radiation at the temperature of 10-40 ℃, and after the reaction is finished, the reaction is quenched.
9. The method for synthesizing an azido amino acid derivative according to claim 8, characterized in that: the synthesis method further comprises the step of carrying out post-treatment on the reaction liquid after the quenching reaction is finished, wherein the post-treatment comprises drying, spin-drying the solvent and purifying by a chromatographic column.
10. The method for synthesizing an azido amino acid derivative according to claim 1, characterized in that: the R is 2 Boc, fmoc; and/or the number of the groups of groups,
the amino protective agent is selected from di-tert-butyl dicarbonate and fluorenylmethoxycarbonyl succinimide; and/or the number of the groups of groups,
in the step S1, the reaction is carried out in the presence of a solvent, wherein the solvent is a mixture of an organic solvent and water, and the organic solvent is one or a combination of a plurality of dioxane, tetrahydrofuran and N, N-dimethylformamide; and/or the number of the groups of groups,
in step S1, the reaction is carried out at 15 to 40℃and in the presence of a base.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311670792.9A CN117658866A (en) | 2023-12-07 | 2023-12-07 | Synthesis method of azido amino acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311670792.9A CN117658866A (en) | 2023-12-07 | 2023-12-07 | Synthesis method of azido amino acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117658866A true CN117658866A (en) | 2024-03-08 |
Family
ID=90076671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311670792.9A Pending CN117658866A (en) | 2023-12-07 | 2023-12-07 | Synthesis method of azido amino acid derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117658866A (en) |
-
2023
- 2023-12-07 CN CN202311670792.9A patent/CN117658866A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chauvette et al. | Chemistry of cephalosporin antibiotics. XXI. Conversion of penicillins to cephalexin | |
Krowicki et al. | Synthesis of novel imidazole-containing DNA minor groove binding oligopeptides related to the antiviral antibiotic netropsin | |
SU1333234A3 (en) | Method of producing the derivatives of n-phenylbenzamide or salts thereof | |
JP2997979B2 (en) | Method for producing 5-aminolevulinic acid | |
KR900001076B1 (en) | Process for the preparation of n-(4-(3-aminopropyl) aminobutyl)-2,2-dihydroxy ethaneamide | |
CN117658866A (en) | Synthesis method of azido amino acid derivative | |
CN110922409A (en) | Method for preparing BTK inhibitor zebritinib | |
US5446166A (en) | Preparation of pyrrol and oxazole compounds: formation of porphyrins and C-acyl-α-amino acid esters therefrom | |
CN113501771A (en) | Preparation method of N- (2-aminoethyl) glycine derivative | |
KR100586671B1 (en) | Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds | |
CN114057668B (en) | Synthesis method of amino protecting group chiral 2-amino-3- (4-morpholinylphenyl) propionic acid | |
KR102577476B1 (en) | Novel amidation method | |
JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
CN113200902B (en) | Polysubstituted pyrrole derivative and preparation method thereof | |
CN111808040B (en) | Synthesis method of multi-configuration 2-oxo-oxazolidine-4-carboxylic acid compounds | |
KR100582751B1 (en) | A Novel Functional Group Protecting Amino Group, Method for Producing the Functional Group, and Method for Synthesizing Peptides | |
KR102188341B1 (en) | Method for Preparation of Apixaban | |
JPS63211264A (en) | Production of indolines | |
Považanec et al. | A new method of preparation of α-amino derivatives of furan | |
SU598871A1 (en) | Method of preparing hydrochloride of methylaminoacetopyrocatechol | |
CN117946104A (en) | Preparation method of iodine-mediated indolo [2,3-b ] quinoline compound in water phase | |
CN116813529A (en) | Synthesis method of 6-tert-butoxycarbonyl-2-amino-6-azaspiro [3.4] octane | |
KR20230174902A (en) | Preparation for Benzoamine derivatives | |
KR100566896B1 (en) | Processes for the preparation of an optically active 5,6-dioxopiperazine-2-carboxylic acid derivative | |
CN117603094A (en) | Synthesis method of amino-protected 2-aminomethyl olefine acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |